Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. [electronic resource]
Producer: 20050919Description: 174-83 p. digitalISSN:- 0094-6176
- Adenosine Diphosphate -- pharmacology
- Animals
- Arteriosclerosis -- complications
- Aspirin -- pharmacology
- Clinical Trials as Topic
- Clopidogrel
- Cohort Studies
- Double-Blind Method
- Drug Resistance
- Fibrinolytic Agents -- pharmacokinetics
- Forecasting
- Humans
- Membrane Proteins -- antagonists & inhibitors
- Meta-Analysis as Topic
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- pharmacokinetics
- Purinergic P2 Receptor Antagonists
- Pyridines -- pharmacology
- Randomized Controlled Trials as Topic
- Rats
- Receptors, Purinergic P2
- Receptors, Purinergic P2Y12
- Thrombophilia -- drug therapy
- Thrombosis -- etiology
- Ticlopidine -- analogs & derivatives
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.